TNFSF10 and hepatocellular carcinoma: In that respect, TRAIL has been proved as a safe and a promising agent for apoptosis-mediated therapy, whereby it offers a fulminant apoptotic effect in various human cancer cell types [17–19], including HCC [20], while showing only negligible effects on normal cells including normal liver cells [17–20].